The vagus nerve is the primary parasympathetic innervation of the lungs, controlling bronchomotor tone, mucus secretion, and airway protective reflexes. Its sensory fibres are the body’s main airway surveillance system — detecting stretch, irritants, and inflammatory mediators and triggering the cough reflex, bronchoconstriction, and changes in breathing pattern. Understanding the vagal role in pulmonary function is clinically relevant to asthma, COPD, chronic cough, and the emerging field of bioelectronic lung medicine.
Vagal Innervation of the Airways
Vagal fibres reach the lungs through the pulmonary plexus, formed at the lung hilum from branches of both vagal trunks. From the plexus, postganglionic parasympathetic fibres travel alongside the bronchial tree, innervating airway smooth muscle, submucosal glands, and the pulmonary vasculature. The innervation is densest in the large and medium airways (trachea and main bronchi) and becomes sparser in the distal bronchioles.
Motor (efferent) fibres. Vagal motor fibres release acetylcholine, which acts on muscarinic M3 receptors on airway smooth muscle cells, producing bronchoconstriction. This is the baseline bronchomotor tone — a tonic level of vagal-mediated airway narrowing that is present at rest. Vagal motor fibres also stimulate submucosal gland secretion (producing the mucus that lines the airways, trapping inhaled particles and microorganisms) and may modulate pulmonary vascular tone.
Sensory (afferent) fibres. Vagal sensory fibres in the airways are the more clinically important component. Three types of sensory receptors are distinguished. Slowly adapting stretch receptors (SARs) in the airway smooth muscle detect lung inflation and mediate the Hering-Breuer reflex — the vagally mediated inhibition of inspiration when the lungs are sufficiently inflated. This reflex prevents overinflation and contributes to the rhythmic pattern of breathing. Rapidly adapting receptors (RARs, also called irritant receptors) respond to mechanical irritation, rapid changes in lung volume, and inhaled irritants. RAR activation triggers cough, bronchoconstriction, and mucus secretion — the triad of airway defensive responses. C-fibre endings (unmyelinated vagal afferents) respond to chemical irritants, inflammatory mediators (bradykinin, prostaglandins, histamine), capsaicin, and changes in tissue pH. C-fibre activation produces the urge to cough, reflex bronchoconstriction, mucus hypersecretion, and airway neurogenic inflammation (through the release of substance P and CGRP from the C-fibre endings themselves).
Vagal Mechanisms in Lung Disease
Asthma
The vagus nerve contributes to asthma pathophysiology through excessive cholinergic bronchoconstriction — the “cholinergic component” of asthma. In asthmatic airways, vagal reflex bronchoconstriction is amplified because airway inflammation sensitises vagal C-fibre endings and RARs, lowering their activation threshold so that normal stimuli (cold air, exercise, allergens) trigger exaggerated vagal reflex bronchoconstriction. Inflammatory mediators (histamine, leukotrienes, prostaglandins) directly activate vagal sensory endings, initiating reflex bronchoconstriction through the vagal efferent pathway. Loss of the M2 muscarinic autoreceptor (which normally limits acetylcholine release from vagal nerve endings) has been demonstrated in asthma — this removes the brake on vagal neurotransmitter release and increases cholinergic bronchoconstriction.
Anticholinergic bronchodilators (ipratropium bromide, tiotropium) treat the vagal component of asthma and COPD by blocking the muscarinic receptors on airway smooth muscle. In COPD, the cholinergic component of airway obstruction is relatively larger than in asthma, and long-acting anticholinergics (tiotropium, umeclidinium) are first-line bronchodilators.
Chronic Cough
Chronic unexplained cough (cough lasting more than 8 weeks without an identifiable cause after standard evaluation) is increasingly understood as a disorder of vagal sensory hypersensitivity — “cough hypersensitivity syndrome.” In this condition, vagal C-fibre and RAR endings in the airway mucosa become hypersensitive, firing in response to stimuli that would not normally trigger cough (talking, laughing, changes in temperature, perfumes). The mechanism parallels chronic pain sensitisation — central and peripheral sensitisation of the cough reflex pathway.
Vagus nerve modulation has been explored as a treatment for refractory chronic cough. gammaCore (non-invasive cervical VNS) has been studied in small chronic cough trials with mixed results. The rationale is that VNS might modulate the sensitised vagal afferent pathways — “resetting” the cough reflex threshold. The evidence is preliminary and the approach remains experimental.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Breathwork
- HRV biofeedback
- Polyvagal-informed therapy
- Somatic therapy
- Craniosacral therapy
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
The Hering-Breuer Reflex and Breathing
The Hering-Breuer reflex — vagally mediated inhibition of inspiration at high lung volumes — is important for understanding the relationship between breathing exercises and vagal function. When you take a deep breath, the stretch receptors in your airways fire, sending afferent signals through the vagus to the brainstem respiratory centres, which inhibit further inspiration and trigger the switch to exhalation.
This reflex means that deep inhalation activates vagal afferents. The subsequent exhalation activates vagal efferents (through respiratory sinus arrhythmia — vagal cardiac output increases during exhalation). Together, deep breathing activates both the sensory and motor components of the vagal pulmonary circuit, which is one reason breathing exercises are such effective vagal training tools.
Emerging Applications
Bioelectronic medicine targeting the vagal pulmonary pathway is an area of active research. Vagal nerve stimulation has shown anti-inflammatory effects in the lungs in animal models of acute lung injury, through the same cholinergic anti-inflammatory pathway that operates in systemic inflammation. Whether VNS could reduce airway inflammation in asthma or COPD in humans is being investigated. Additionally, the identification of specific vagal sensory fibre subtypes through single-cell sequencing of vagal sensory ganglia is opening the possibility of selectively targeting specific vagal pathways — for example, silencing cough-triggering C-fibres without affecting the protective stretch receptor reflexes.
The vagus nerve is the gatekeeper of your airways — controlling bronchomotor tone, the cough reflex, and airway immune surveillance. My Vagus Nerve & Me maps the full vagal circuitry and explains how it affects every system in your body, including your lungs. Get My Vagus Nerve & Me eBook and understand the breadth of vagal influence.
